Copyright
©The Author(s) 2025.
World J Gastroenterol. Jun 14, 2025; 31(22): 106937
Published online Jun 14, 2025. doi: 10.3748/wjg.v31.i22.106937
Published online Jun 14, 2025. doi: 10.3748/wjg.v31.i22.106937
Figure 3 Graphical abstract.
MASLD: Metabolic dysfunction-associated steatotic liver disease; EVs: Extracellular vesicles; ROC-AUC: Receiver operating characteristic-area under the curve; C1: Case 1; C2: Case 2; UAP: Ultrasound Attenuation Parameter; ML: Machine learning. Created in BioRender (Supplementary material).
- Citation: Trifylli EM, Angelakis A, Kriebardis AG, Papadopoulos N, Fortis SP, Pantazatou V, Koskinas J, Kranidioti H, Koustas E, Sarantis P, Manolakopoulos S, Deutsch M. Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence. World J Gastroenterol 2025; 31(22): 106937
- URL: https://www.wjgnet.com/1007-9327/full/v31/i22/106937.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i22.106937